PPT-Safety Findings of the Phase I Study of Conivaptan for Cerebral Edema in ICH
Author : isabella | Published Date : 2022-04-06
Jesse J Corry MD John Nasseff Neuroscience Specialty Clinic United Hospital part of Allina Health Division of Stroke Neurology Division of Inpatient Neurology Disclosures
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Safety Findings of the Phase I Study of ..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Safety Findings of the Phase I Study of Conivaptan for Cerebral Edema in ICH: Transcript
Jesse J Corry MD John Nasseff Neuroscience Specialty Clinic United Hospital part of Allina Health Division of Stroke Neurology Division of Inpatient Neurology Disclosures Nothing relevant to this study. Navaz Karanjia, MD. Director. . of . Neurocritical. Care. Assistant Professor of Neurosciences, Neurosurgery, and Anesthesiology. University of California. -. San Diego Health System. Financial: none. The Many Presentations of Reversible Cerebral Vasoconstriction . Syndrome (RCVS), . A Great Masquerader. . Katyucia De Macedo Rodrigues, Eduardo . Scortegagna. Jr., Deepak . Takhtani. , . Ajit. . Puri. Management of Cerebral Edema and Increased Intracranial Pressure. Deepak S Nair, MD. Stroke Neurology & . Neurocritical. Care. OSF Healthcare – Illinois Neurological Institute. Disclosures. No financial (or other) conflicts of interest to disclose. Bhatia. Radiology elective . 06/02/17. J. P.. 25 y/o M. Presented to Ed C/o persistent headaches over several months. Feels dull & in the back of his head with intermittent, sharp neck pain. Headaches worse over last week, . . Krauss GL, Perucca E, Ben-Menachem E, Kwan P, Shih JJ, Squillacote D, Yang H, Gee M, Zhu J, Laurenza A. Perampanel, a selective, non-competitive AMPA receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from Phase III, extension study 307. IGHALTITUDECEREBRALEDEMAis a mysterious and infrequent maladyhigh altitude. We define it as a condition oc-curring in persons who have recently arrivedmountain sickness or high altitude pulmonaryHACE (OPERATION WEALTH CREATION, YOUTH LIVELIHOOD PROGRAMME AND COMMUNITY AGRICULTURAL INFRASTRUCTURE IMPROVEMENT PROGRAMME).. DRAFT REPORT. By. . July 27, 2016. 1. . CARITAS UGANDA (CU). THE UGANDA FARMERS’ . INTRACRANIAL . PRESSURE; CEREBRAL EDEMA, BRAIN TUMORS. Assoc. Prof. Ingrid . Miron. INCREASED INTRACRANIAL PRESSURE. SYMPTOMS. Headaches. . of recent . onset. . and. . increasing. . severity. . associated. Student Name:. Faculty Mentor:. Period: Date:. History- . 1 slide only. Example:. 57 F. SOB and chest pain X 12 hours. Elevated D-Dimer. Previously healthy. Only include RELEVANT history and physical exam findings and labs. Sarah Kandil MD. November 14. th. 2019. Date. Disclosure/COI. Co-Investigator for Pfizer PHASE 1 study assessing pharmacokinetics, safety and tolerability of ceftazidime-avibactam (. caz-avi. ) in children.. . . Consciousness. defined as being awake and aware of both one’s self and one’s surroundings, OR it is . the human . awareness. Traumatic cerebral contusion: pathobioHernando Alvis-Miranda, Gabriel Alcala-Cerra, Luis Rafael Moscote-SalazarUniversidad de Cartagena Traumatic brain injury is a major cause of mortality in develo Simon M, Hernu R, Cour M, Casalegno J, Lina B, Argaud L. Fatal Influenza A(H1N1)pdm09 Encephalopathy in Immunocompetent Man. Emerg Infect Dis. 2013;19(6):1005-1007. https://doi.org/10.3201/eid1906.130062. What is cerebral edema?. Cerebral edema is a life-threatening condition that develops as a result of an inflammatory . cascade. . Most . frequently, this is the consequence of cerebral trauma, massive cerebral infarction, hemorrhages, abscess, tumor, allergy, sepsis, .
Download Document
Here is the link to download the presentation.
"Safety Findings of the Phase I Study of Conivaptan for Cerebral Edema in ICH"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents